A clinical trial in Japan for a drug to treat sufferers of acute strokes has hit a snag due to surging import costs, prompting doctors to run a crowdfunding campaign to maintain the trial.
Stroke doctors such as Manabu Inoue of the National Cerebral and Cardiovascular Center in Osaka Prefecture are currently trying to get domestic approval for tenecteplase, a clot-busting drug for brain infarction, more commonly known as a stroke.
With your current subscription plan you can comment on stories. However, before writing your first comment, please create a display name in the Profile section of your subscriber account page.